
Y.S.P. Industries (M) Sdn. Bhd.
Y.S.P. SOUTHEAST ASIA HOLDING BHD. 200101017024 (552781-X) Notice under Personal Data Protection Act: HOME: ABOUT US: INVESTOR: MARKETING INFORMATION: CAREER: CONTACT INFO: ADR REPORTING: Y.S.P. SOUTHEAST ASIA HOLDING BHD. 200101017024 (552781-X) Notice under Personal Data Protection Act ...
Investor - yspsah.com
At , our strength lies in our unwavering commitment in harnessing the best of our resources, both manpower and technology. In fact, we have made a thrust in the global marketplace through …
Yungshingroup - Y.S.P. Southeast Asia Holding Berhad
Today the Group boasts a wide array of pharmaceutical, over-the-counter (OTC), veterinary and aquatic products, with regional offices as well as strategic alliances in Singapore, Vietnam, Philippine, Myanmar, Cambodia, Thailand, Indonesia, Brunei, Laos , as well as Sri Lanka, Africa and countries in Middle East.
Branch Offices In Malaysia - yspsah.com
To satisfy market demand instantly, we have built a 5,400 square meter logistics centre which complies with GMP and GSP regulations. With our ERP information system and computer assisted picking system, we can process over 3,000 purchase order daily to provide prompt delivery and services to our customers.
永信國際投資控股 - 永信東南亞控股有限公司
y.s.p. southeast asia holding berhad(y.s.p. sah)為根據1965年公司法令,於2001年7月在馬來西亞這冊成立之投資控股公司,其子公司主要從事進口、出口、貿易及生產人用藥物、動物藥物、水產藥物與藥劑化學等產品。
YSP Southeast Asia Holding Bhd (YSPSAH) Stock Price & News
Get the latest YSP Southeast Asia Holding Bhd (YSPSAH) real-time quote, historical performance, charts, and other financial information to help you make more informed trading and investment...
Yungshingroup - YungShin Industries (Malaysia) Sdn Bhd
With research-based production, at YSP Malaysia we produce quality tablets, capsules, suppositories, and ointments. The products we carry include OTC, animal and aquacultural medicine. We constantly introduce new production technologies and develop new products, and we achieve sustainable management with quality products.
YSPSAH: Y.S.P. SOUTHEAST ASIA HOLDING BERHAD (7178)
2003年9月30日 · Pharmaceutical company YSP Southeast Asia Holding Bhd (KL:YSPSAH)’s net profit fell 41.9% to RM3.47 million in the third quarter ended Sept 30, 2024 (3QFY2024), from RM5.98 million a year ago, dragged by foreign exchange (forex) loss and lower sales.
Y.S.P.SOUTHEAST ASIA HOLDING BERHAD (7178) - Bursa Malaysia
2025年3月21日 · 22 Apr 2024 First and Final Dividend. EX-date: 24 Jun 2024. Entitlement date: 25 Jun 2024. Entitlement description: Final Single-tier Ordinary Dividend of 8.0 sen per ordinary share and Final Single-tier Special...
YSPSAH (7178) Overview - Y.S.P.SOUTHEAST ASIA HOLDING
Y SP Southeast Asia Holding Bhd is an investment company, which engages in the pharmaceutical business, provision of management services. It operates through the following segments: Trading, Manufacturing and Investment Holding.